Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7317)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 27, 2023 (publication date) through Jan 7, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wang L, Liu BX, Long HY. Ablative strategies for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(4): 515-524 [PMID: 37206650 DOI: 10.4254/wjh.v15.i4.515] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Wang L, Liu BX, Long HY. Ablative strategies for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(4): 515-524 [PMID: 37206650 DOI: 10.4254/wjh.v15.i4.515] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i4/515.htm |
| Number | Citing Articles |
| 1 |
Hao Li, Shuguang Ju, Jiacheng Wang, Donglin Kuang, Pengfei Chen, Mengfan Zhang, Ruijie Qian, Chao Liang, Daqian Han, Xuhua Duan. Tanshinone IIA inhibits heat-induced growth of p53-mutant Huh-7 hepatocellular carcinoma by modulating osmotic homeostasis and glycolysis through targeting ALDH7A1. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02795-0
|
| 2 |
Xi Mao, Xiaoya Zhu, Tong Pan, Zehui Liu, Pingping Shangguan, Yi Zhang, Yingle Liu, Xiwen Jiang, Qi Zhang. Apelin (APLN) is a biomarker contributing to the diagnosis and prognosis of hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71495-z
|
| 3 |
Orane Lorton, Pauline Coralie Guillemin, Andrea Peloso, Yacine M’Rad, Lindsey Alexandra Crowe, Thibaud Koessler, Pierre-Alexandre Poletti, Sana Boudabbous, Alexis Ricoeur, Rares Salomir. In Vivo Thermal Ablation of Deep Intrahepatic Targets Using a Super-Convergent MRgHIFU Applicator and a Pseudo-Tumor Model. Cancers 2023; 15(15): 3961 doi: 10.3390/cancers15153961
|
| 4 |
Tiffany Nakla, Jacqueline J. Chow, Kathleen Pham, Nadine Abi-Jaoudeh. Non-Thermal Liver Ablation: Existing and New Technology. Seminars in Interventional Radiology 2023; 40(06): 497 doi: 10.1055/s-0043-1777844
|
| 5 |
Ching-Lung Hsieh, Cheng-Ming Peng, Chun-Wen Chen, Chang-Hsien Liu, Chih-Tao Teng, Yi-Jui Liu. Benefits and drawbacks of radiofrequency ablation <i>via</i> percutaneous or minimally invasive surgery for treating hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2024; 16(11): 3400-3407 doi: 10.4240/wjgs.v16.i11.3400
|
| 6 |
Zixuan Gao, Linmei Yao, Xin Wei, Shuojie Wang, Weihua Cao, Wen Deng, Xinxin Li, Ziyu Zhang, Shiyu Wang, Yaqin Zhang, Minghui Li, Yao Xie. Progress in the Application of Nanobiotechnology in the Ablation Therapy of Hepatic Carcinoma. International Journal of Nanomedicine 2025; : 15109 doi: 10.2147/IJN.S551980
|
| 7 |
Mohammad SS Naviwala, Waqas A Khan, Adeeba Zaki, Mahnoor Tariq, Faiza Ahmed, Warda Saleem, Munira Moosajee, Yasmin A Rashid, Armish Rehman. Assessing the Predictive Value of NLR and PLRs in Advanced Hepatocellular Carcinoma Patients Receiving First-line Systemic Therapy: Observations from a Tertiary Care Hospital in Pakistan. Euroasian journal of hepato-gastroenterology 2025; 15(1): 107 doi: 10.5005/jp-journals-10018-1462
|
| 8 |
Wen Liu, Jun Deng, Xiao-Jun Tao, Ya Peng, Xiang-Ding Chen, Xiao-Chao Qu, Hong-Wen Deng, Li-Jun Tan. Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3. International Journal of Oncology 2024; 65(4) doi: 10.3892/ijo.2024.5680
|
| 9 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
| 10 |
Zhenyu Wen, Junxiao Wang, Bo Tu, Yane Liu, Yuqing Yang, Li Hou, Xiang Yang, Xiaoyan Liu, Hui Xie. Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial. Cancer Medicine 2023; 12(20): 20311 doi: 10.1002/cam4.6602
|
| 11 |
Farag M.A. Altalbawy, Ahmed Hussein Zwamel, Gaurav Sanghvi, R. Roopashree, Mukesh Kumari, Aditya Kashyap, S. Gayathri, Rajashree Panigrahi. Interactions in hepatic tumor microenvironment: Potential targets and modulations for effective therapy. Pathology - Research and Practice 2025; 272: 156074 doi: 10.1016/j.prp.2025.156074
|
| 12 |
Cheng-Ming Peng, Shao-Chieh Lin, Yung-Yin Cheng, Teng-Chieh Cheng, Ching-Lung Hsieh, Chia-Hong Hsieh, Mei-Fang Hsieh, Chun-Han Liao, Ming-Cheng Liu, Yi-Jui Liu. Outcomes of robotic liver resection and intraoperative radiofrequency ablation for hepatocellular carcinoma in posterior segments VII and VIII. World Journal of Gastrointestinal Surgery 2025; 17(12): 113940 doi: 10.4240/wjgs.v17.i12.113940
Abstract(15) |
Core Tip(11) |
Full Article(HTML)(58)
|
Full Article with Cover (PDF)-2252K(4)
|
Audio-1172K(2)
|
Peer-Review Report-217K(6)
|
Answering Reviewers-655K(5)
|
Supplementary Material-499K(4)
|
Full Article (PDF)-1928K(12)
|
Full Article (XML)-176K(7)
|
Times Cited (0)
|
Total Visits (590)
|
Open
|
| 13 |
Wen-jun Pei, Hao Zhou, Ying Zeng, Qi-lin Ji, Jing-jing Zhang, Xiu Wang. 3-Bromopyruvate modified with cholesterol enhances anti-hepatoma activity by inducing ferroptosis and apoptosis. Journal of Drug Delivery Science and Technology 2025; 103: 106426 doi: 10.1016/j.jddst.2024.106426
|
| 14 |
Jizhen Yang, Xiaomei Chen, Juanjuan Liang, Zubang Zhou. The prognostic role of pre-treatment alpha-fetoprotein in hepatocellular carcinoma patients undergoing radiofrequency ablation: A meta-analysis. Asian Journal of Surgery 2025; 48(10): 6631 doi: 10.1016/j.asjsur.2025.05.014
|